Role of type II pneumocytes in pathogenesis of radiation pneumonitis: dose response of radiation-induced lung changes in the transient high vascular permeability period

2004 ◽  
Vol 56 (3) ◽  
pp. 181-187 ◽  
Author(s):  
Jan Österreicher ◽  
Jaroslav Pejchal ◽  
Jiří Škopek ◽  
Jaroslav Mokrý ◽  
Zdena Vilasová ◽  
...  
1993 ◽  
Vol 265 (3) ◽  
pp. L250-L259
Author(s):  
E. H. Webster ◽  
S. R. Hilfer ◽  
R. L. Searls ◽  
J. Kornilow

The mesodermal capsule of the fetal lung plays a role in differentiation of the respiratory region. It has been proposed for other epithelial organs that the mesodermal capsule influences development by modifying the basal lamina or the extended extracellular matrix. The effect could be on deposition or turnover of collagens, proteoglycans, and/or glycoproteins. This study tests the role of glycoproteins in differentiation of respiratory endings by inhibiting their synthesis with the antibiotic tunicamycin (TM). Lungs at 16 and 18 days gestation and 3 days after birth were cultured with TM and examined for morphological and biochemical differences from normal controls. With TM, alveolar regions did not expand properly and formed fewer type I pneumocytes, although type II pneumocytes were unaffected. The epithelium of untreated respiratory regions showed greater incorporation of radioactive mannose than the airways region or mesenchyme. This incorporation was diminished in TM, but the pattern persisted. Comparison with the results obtained with beta-xyloside suggested that differentiation of type I and type II pneumocytes is under separate control.


2013 ◽  
Vol 105 (19) ◽  
pp. 1474-1484 ◽  
Author(s):  
Deborah E. Citrin ◽  
Uma Shankavaram ◽  
Jason A. Horton ◽  
William Shield ◽  
Shuping Zhao ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (9) ◽  
pp. e45028 ◽  
Author(s):  
Kari Fine-Coulson ◽  
Barbara J. Reaves ◽  
Russell K. Karls ◽  
Frederick D. Quinn

2009 ◽  
Vol 14 (4) ◽  
pp. 417-425 ◽  
Author(s):  
Lan Song ◽  
Xing Wei ◽  
Bin Zhang ◽  
Xinjing Luo ◽  
Junwen liu ◽  
...  

1984 ◽  
Vol 10 (3) ◽  
pp. 375-378 ◽  
Author(s):  
Donald L. Shapiro ◽  
Jacob N. Finkelstein ◽  
Philip Rubin ◽  
David P. Penney ◽  
Dietmar W. Siemann

1984 ◽  
Vol 121 (1) ◽  
pp. 215-225 ◽  
Author(s):  
Jamson S. Lwebuga-Mukasa ◽  
Gunilla Thulin ◽  
Joseph A. Madri ◽  
Carolyn Barrett ◽  
Joseph B. Warshaw

2020 ◽  
pp. 4271-4272
Author(s):  
S. J. Bourke

The lungs can be injured by radiation used in the treatment of cancer, with the rapidly dividing endothelial cells and type II pneumocytes most affected. Immediate injury is followed by an inflammatory response and at a later stage by fibrosis. Chest radiography detects asymptomatic changes in about 50% of patients after radiotherapy. Acute radiation pneumonitis presents with cough, breathlessness, and fever about 2 months after exposure; corticosteroids are usually effective in relieving symptoms but do not prevent the subsequent development of fibrosis. Fibrosis typically develops about 6 months later, may progress for 6–24 months, but has usually stabilized by 2 years. Prevention depends on refining techniques for giving radiotherapy.


CytoJournal ◽  
2014 ◽  
Vol 11 ◽  
pp. 2 ◽  
Author(s):  
Anjali Saqi ◽  
Shana M. Coley ◽  
John P. Crapanzano

Background: Fine-needle aspirations (FNAs) and core biopsies (CBs), with or without touch preparations (TPs), are performed to characterize pulmonary lesions. Although a positive (P) or suspicious report is sufficient for further management, the significance of unsatisfactory (U), negative (N) and atypical (A) cytological diagnoses remains uncertain. The aims of the study were to correlate U, N and A cytological diagnoses with histological and/or clinical/radiological follow-up and evaluate the utility of FNAs, TPs and CBs. Materials and Methods: We performed a retrospective search and examined 30 consecutive computed tomography-guided transthoracic U, N and A lung FNAs (n = 23) and TPs (n = 7) with surgical pathology (SP) (n = 17) and/or clinical/radiological follow-up (n = 13) and compared them to 10 SP-confirmed P FNAs, which served as controls. Results: The 30 FNAs and TPs were from 29 patients. All 6 U specimens were scantly cellular. Granulomas, the most common specific benign cytological diagnosis, were evident in 8 (of 13) and 7 (of 11) N and A cytology cases, respectively. Histology corroborated the presence of granulomas identified on cytology. Organizing pneumonia was the second leading benign specific diagnosis (5/17), but it was rendered on histology (n = 5) and not FNAs or TPs. Evaluation of the A cases revealed that type II pneumocytes were the source of “atypical”, diagnoses often associated with granulomas or organizing pneumonia and lacked 3-D clusters evident in all P cases. Discussion: U, N and A FNAs and TPs lacked 3-D clusters seen in carcinomas and were negative on follow-up. Granulomas and organizing pneumonia were the most common specific benign diagnoses, but the latter was recognized on histology only. In the absence of a definitive FNA result at the time of on-site assessment, a CB with a TP containing type II pneumocytes increases the likelihood of a specific benign diagnosis.


2008 ◽  
Vol 295 (4) ◽  
pp. L658-L669 ◽  
Author(s):  
Sandra R. Bates ◽  
Altaf S. Kazi ◽  
Jian-Qin Tao ◽  
Kevin J. Yu ◽  
Daniel S. Gonder ◽  
...  

We have recently described a putative receptor for lung surfactant protein-A (SP-A) on rat type II pneumocytes. The receptor, P63, is a 63-kDa type II transmembrane protein. Coincubation of type II cells with P63 antibody (Ab) reversed the inhibitory effect of SP-A on secretagogue-stimulated surfactant secretion from type II cells. To further characterize SP-A interactions with P63, we expressed recombinant P63 protein in Escherichia coli and generated antibodies to P63. Immunogold electron microscopy confirmed endoplasmic reticulum and plasma membrane localization of P63 in type II cells with prominent labeling of microvilli. Binding characteristics of iodinated SP-A to type II cells in the presence of P63 Ab were determined. Binding (4°C, 1 h) of 125I-SP-A to type II cells demonstrated both specific (calcium-dependent) and nonspecific (calcium-independent) components. Ab to P63 protein blocked the specific binding of 125I-SP-A to type II cells and did not change the nonspecific SP-A association. A549 cells, a pneumocyte model cell line, expressed substantial levels of P63 and demonstrated specific binding of 125I-SP-A that was inhibited by the P63 Ab. The secretagogue (cAMP)-stimulated increase in calcium-dependent binding of SP-A to type II cells was blocked by the presence of P63 Ab. Transfection of type II cells with small interfering RNA to P63 reduced P63 protein expression, attenuated P63-specific SP-A binding, and reversed the ability of SP-A to prevent surfactant secretion from the cells. Our results further substantiate the role of P63 as an SP-A receptor protein localized on the surface of lung type II cells.


2010 ◽  
pp. 3458-3460
Author(s):  
S.J. Bourke ◽  
D.J. Hendrick

The lungs can be injured by radiation used in cancer treatment, with the rapidly dividing endothelial cells and type II pneumocytes most affected. Immediate injury is followed by an inflammatory response and at a later stage by fibrosis. Chest radiography reveals asymptomatic changes in about 50% of patients after radiotherapy. ...


Sign in / Sign up

Export Citation Format

Share Document